NEUROVIA
NeuroVia, Inc. is committed to addressing unmet medical needs in neurological diseases with the primary goal to arrest the onset of devastating neurological deficits associated with X-ALD.
NEUROVIA
Social Links:
Industry:
Biopharma Biotechnology Medical Therapeutics
Founded:
2013-01-01
Address:
San Francisco, California, United States
Country:
United States
Website Url:
http://www.neurovia-inc.com
Total Employee:
51+
Status:
Closed
Contact:
(415)870-6967
Email Addresses:
[email protected]
Total Funding:
14 M USD
Technology used in webpage:
IPv6 Cloudflare Hosting Cloudflare DNS
Current Advisors List
Current Employees Featured
Founder
Investors List
Enso Ventures
Enso Ventures investment in Series A - NeuroVia
Sanofi Ventures
Sanofi Ventures investment in Series A - NeuroVia
BioMed Ventures
BioMed Ventures investment in Series A - NeuroVia
Novartis Venture Fund
Novartis Venture Fund investment in Series A - NeuroVia
More informations about "NeuroVia"
NeuroVia - Crunchbase Company Profile & Funding
NeuroVia, Inc. is committed to addressing unmet medical needs in neurological diseases with the primary goal to arrest the onset of devastating neurological deficits associated with X-ALD.See details»
Neurovia Company Profile 2024: Valuation, Funding
Developer of therapies designed to offer treatment for neurological disorders. The company's therapies have developed a selective thyromimetic agent for the treatment of X-linked adrenoleukodystrophy, enabling X-ALD patients to get …See details»
NeuroVia, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Explore NeuroVia, Inc. with its drug pipeline, therapeutic area, technology platform, 3 clinical trials, Technology Platform:Small molecule drug, Drug:Sobetirome.See details»
NeuroVia Inc - Company Profile and News - Bloomberg Markets
NeuroVia, Inc. operates as a biopharmaceutical company. The Company develops therapies for neurological diseases. NeuroVia serves doctors and patients in the United States.See details»
NeuroVia - Products, Competitors, Financials, Employees, …
NeuroVia is a specialty pharmaceutical company focused on developing therapeutics for orphan disease with significant unmet medical need. Use the CB Insights Platform to explore …See details»
NeuroVia Company Profile - Office Locations, Competitors ... - Craft
NeuroVia is a biopharmaceutical company developing therapeutics for the treatment of orphan neurologic disease. NeuroVia’s lead drug candidate, NV1205, is being developed for the …See details»
NeuroVia - Funding, Financials, Valuation & Investors - Crunchbase
NeuroVia is a biopharmaceutical company.See details»
NeuroVia - Overview, News & Similar companies | ZoomInfo.com
Jul 24, 2018 · View NeuroVia (www.ccald.com) location in California, United States , revenue, industry and description. Find related and similar companies as well as employees by title and …See details»
NeuroVia - Contacts, Employees, Board Members, Advisors & Alumni
NeuroVia has 1 current employee profile, Executive Director Thomas Scanlan. NeuroVia has 3 board members and advisors, including Jason P. Hafler.See details»
NeuroVia Inc. - BioCentury Company Profiles - BCIQ
NeuroVia Inc. - BioCentury Company Profiles for the biopharma industrySee details»
NeuroVia Closes Series A Financing Round of $14M to Develop …
Jul 20, 2017 · CAMBRIDGE, Mass.-- ( BUSINESS WIRE )--NeuroVia, Inc., a biopharmaceutical company focused on developing innovative therapies for rare genetic neurological diseases, …See details»
OHSU startup receives $11.45 million to help treat neurologic …
Dec 29, 2015 · NeuroVia, Inc., an OHSU startup company, recently closed Series A equity financing, raising $11.45 million to support the company’s mission and commitment to …See details»
Backed by Novartis AG and Sanofi, NeuroVia Banks $14 Million
Jul 20, 2017 · CAMBRIDGE, Mass.--(BUSINESS WIRE)--NeuroVia, Inc., a biopharmaceutical company focused on developing innovative therapies for rare genetic neurological diseases, …See details»
Innovative Blood Pressure Management Solutions by Neurovia ...
Neurovia Bioelectronics transforms blood pressure management with a reversible, minimally-invasive stent, targeting autonomic dysfunctions and improving lives, especially for those aged …See details»
NeuroVia Initiates Phase 1/2 Trial of NV1205 for Treating …
Jul 25, 2018 · NeuroVia, Inc. is committed to addressing unmet medical needs in neurological diseases with the primary goal to arrest the onset of devastating neurological deficits …See details»
Neurovia Bioelectronics - Crunchbase Company Profile & Funding
Neurovia Bioelectronics is revolutionizing blood pressure management by offering innovative solutions to improve health outcomes and quality of life. It utilizes established microfabrication …See details»
Novartis, Sanofi-backed NeuroVia closes $14M series A for X-ALD …
Jul 20, 2017 · Sanofi Genzyme and Novartis’ venture arms have backed NeuroVia, an upstart that wants to help treat the rare CNS disorder X-linked adrenoleukodystrophy.See details»
NeuroVia Initiates Phase 1/2 Trial of NV1205 for Treating
Jul 25, 2018 · NeuroVia, Inc. is committed to addressing unmet medical needs in neurological diseases with the primary goal to arrest the onset of devastating neurological deficits …See details»
Sobetirome - NeuroVia - AdisInsight - Springer
Nov 4, 2017 · If your organization has a subscription, there are several access options, even while working remotely: Working within your organization’s network Login with username/password …See details»
NeuroVia, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Explore NeuroVia, Inc. with its drug pipeline, therapeutic area, technology platform, 2 clinical trials, Drug:Sobetirome.See details»